Cancel
See Linkedin
About Lindsay Pino
Lindsay Pino is the CTO and Co-Founder of Talus Bio, recognized for her contributions to proteomics and drug discovery.
Known information
Lindsay Pino is the Chief Technology Officer and Co-Founder of Talus Bio, a company she co-founded in 2020. She holds a Ph.D. and has been featured in The Proteomics Show podcast. Pino developed a platform called MARMOT, which is designed to discover drugs that target transcription factors. She is part of an interdisciplinary team at Talus Bio that pioneers proteomics-first drug discovery for transcription factors. Her work has garnered more than 6,800 citations, and she has been recognized as one of the ‘40-under-40’ proteomicists.
About Talus Bio
Talus Bio, based in Seattle, WA, is a healthcare company specializing in drug discovery and delivery, focusing on previously undruggable genome regulators. They have developed MARMOT, a platform for targeting transcription factors in their native environments.
Report inaccurate information
